Skip to main content
Clinical Trials/NCT05594225
NCT05594225
Active, not recruiting
Phase 1

Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk

University of Colorado, Denver1 site in 1 country88 target enrollmentAugust 23, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Brain Concussion
Sponsor
University of Colorado, Denver
Enrollment
88
Locations
1
Primary Endpoint
Injury rate
Status
Active, not recruiting
Last Updated
9 months ago

Overview

Brief Summary

The goal of this clinical trial is to examine the feasibility, utility, and efficacy of a smartphone-based assessment battery and remotely administered virtual Neuromuscular/Dual-Task (vNDT) intervention among healthy U.S. military service members and physically active young adults with a recent concussion.

Detailed Description

Aim 1. Determine the baseline neuromuscular/dual-task performance characteristics among a sample of active-duty military service members compared to physically active young adult civilians. The investigators hypothesize that active-duty military service members will have similar baseline gait and dual-task abilities as civilians, demonstrating translation potential between populations. The investigators also hypothesize that baseline gait and dual-task abilities will be influenced by history of prior mTBI injuries among military Service Members. Aim 2. Examine the efficacy of a smartphone-based vNDTT intervention to reduce musculoskeletal injury and improve neuromuscular/dual-task performance after a recent mTBI. The investigators hypothesize that those randomized to the intervention within three weeks of mTBI will have a lower risk of MSK injury in the 3-month period following mTBI, relative to standard-of-care. The investigators also hypothesize that those randomized to the intervention within three weeks of mTBI will have better post-intervention gait and dual-task performance than those assigned to standard-of-care, despite similar baseline performance.

Registry
clinicaltrials.gov
Start Date
August 23, 2023
End Date
September 30, 2025
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-40 years of age at the time of enrollment
  • Mild TBI or concussion diagnosis by a physician
  • Confirmed MTBI diagnosis via VA/DOD guidelines at time of enrollment
  • Participation in regular physical activity prior to injury (confirmed via the Global Physical Activity Questionnaire \[GPAQ\]) (Cleland et al., 2014; Keating et al., 2019)
  • Access to a smartphone for app download

Exclusion Criteria

  • Moderate or severe TBI
  • Pre-injury neurological disorder
  • Abnormal brain imaging findings (if performed as a part of routine care)
  • Previous TBI (mild/moderate/severe) \<12 months prior to enrollment other than the current injury for which they are being seen

Outcomes

Primary Outcomes

Injury rate

Time Frame: 3 months after mTBI

Acute musculoskeletal injury rate

Secondary Outcomes

  • Intervention adherence(Upon enrollment and for the subsequent 8 weeks)
  • Sleep quality(During the initial (post-injury) evaluation and again at the follow-up (8 weeks after initial evaluation) test)
  • Single/dual-task standing and gait(During the initial (post-injury) evaluation and again at the follow-up (8 weeks after initial evaluation) test)
  • Quality of Life Domains: Mobility, Depressive Symptoms, Fatigue, Pain Interference(During the initial (post-injury) evaluation and again at the follow-up (8 weeks after initial evaluation) test)
  • Dizziness(During the initial (post-injury) evaluation and again at the follow-up (8 weeks after initial evaluation) test)
  • Anxiety(During the initial (post-injury) evaluation and again at the follow-up (8 weeks after initial evaluation) test)

Study Sites (1)

Loading locations...

Similar Trials